The Impact of GLP-1 Drugs on Reward Pathways
We examine the impact of GLP-1 drugs such as Ozempic on reward pathways and the dopamine system.
Move Over Ozempic, Here Comes Petrelintide
Roche has signed a multi-billion dollar deal with Zealand Pharma to develop the weight loss drug petrelintide.
Controlled-Release Medication Could Improve Outcomes in Addiction Treatment
Researchers at VCU have formulated a drug that works better than methadone or buprenorphine at treating opioid use disorder.
17 Percent of Gambling Families Facing Bankruptcy
A new Intuit Credit Karma survey offers a wealth of information on gambling addiction.
New Documentary on Addiction Treatment Fraud Wins at SXSW
The documentary, “Shuffle,” follows three patients through three years of addiction treatment in Florida.
Deep Brain Stimulation for Addiction Treatment
Two hospitals in England are teaming up to test the Brain-PACER deep brain stimulation treatment for substance use disorders.